Last reviewed · How we verify
Timing of prophylactic antibiotic administration
Timing of prophylactic antibiotic administration is a Small molecule drug developed by University of Pennsylvania. It is currently FDA-approved for Prevention of surgical site infections across various surgical procedures.
This is a clinical practice guideline or protocol for optimizing the timing of prophylactic antibiotic administration to reduce surgical site infections, not a pharmaceutical drug.
This is a clinical practice guideline or protocol for optimizing the timing of prophylactic antibiotic administration to reduce surgical site infections, not a pharmaceutical drug. Used for Prevention of surgical site infections across various surgical procedures.
At a glance
| Generic name | Timing of prophylactic antibiotic administration |
|---|---|
| Sponsor | University of Pennsylvania |
| Modality | Small molecule |
| Therapeutic area | Surgical prophylaxis / Infection prevention |
| Phase | FDA-approved |
Mechanism of action
This entry refers to a standardized approach to perioperative antibiotic prophylaxis timing rather than a specific drug product. The mechanism involves administering antibiotics at optimal intervals before surgical incision to achieve adequate tissue concentrations at the time of surgery, thereby reducing the risk of surgical site infections. This is a procedural/administrative intervention rather than a pharmacological agent.
Approved indications
- Prevention of surgical site infections across various surgical procedures
Common side effects
Key clinical trials
- Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study (PHASE4)
- Amoxicillin and Metronidazole During or After the Periodontal Treatment (NA)
- The Timing of Prophylactic Antibiotics in Cesarean Section and the Risk of Post-operative Febrile Morbidity (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Timing of prophylactic antibiotic administration CI brief — competitive landscape report
- Timing of prophylactic antibiotic administration updates RSS · CI watch RSS
- University of Pennsylvania portfolio CI
Frequently asked questions about Timing of prophylactic antibiotic administration
What is Timing of prophylactic antibiotic administration?
How does Timing of prophylactic antibiotic administration work?
What is Timing of prophylactic antibiotic administration used for?
Who makes Timing of prophylactic antibiotic administration?
What development phase is Timing of prophylactic antibiotic administration in?
Related
- Manufacturer: University of Pennsylvania — full pipeline
- Therapeutic area: All drugs in Surgical prophylaxis / Infection prevention
- Indication: Drugs for Prevention of surgical site infections across various surgical procedures
- Compare: Timing of prophylactic antibiotic administration vs similar drugs
- Pricing: Timing of prophylactic antibiotic administration cost, discount & access